Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service.
Westerhout KY, Bouwmeester W, Duchesne I, Pisini M, Piena MA, Damele F, Gueron B, Treur M, Belsey J. Westerhout KY, et al. Clinicoecon Outcomes Res. 2017 Feb 27;9:163-172. doi: 10.2147/CEOR.S117650. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 28280374 Free PMC article.
Cost-Utility Analysis of Simeprevir With Peginterferon + Ribavirin (SMV/PR) in the Management of Genotype 1 (G1) and 4 (G4) Hepatitis C Virus (HCV) Infection; from the Perspective of the Uk National Health Service (NHS).
Westerhout KY, Treur M, Mehnert A, Pascoe K, Ladha I, Belsey J. Westerhout KY, et al. Value Health. 2014 Nov;17(7):A679. doi: 10.1016/j.jval.2014.08.2527. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202509 Free article. No abstract available.
[No authors listed] [No authors listed] PMID: 26534670
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page